Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Maltese IBD study-cases treatment naïve

ABSTRACT: Dysbiosis of the gut microbiota in Maltese patients with Inflammatory Bowel Disease-cases treatment naïve

PROVIDER: PRJEB47161 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR6558700_1.fastq.gz	Fastqsanger.gz
	ERR6558700_2.fastq.gz	Fastqsanger.gz
	ERR6558710_1.fastq.gz	Fastqsanger.gz
	ERR6558710_2.fastq.gz	Fastqsanger.gz
	ERR6558720_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 112

Similar Datasets

Maltese IBD study - cases remission

Project description:Dysbiosis of the gut microbiota in Maltese patients with Inflammatory Bowel Disease - cases remission

| PRJEB44440 | ENA

Maltese IBD study-healthy controls

Project description:Dysbiosis of the gut microbiota in Maltese patients with Inflammatory Bowel Disease-healthy controls

| PRJEB47162 | ENA

RNA-seq of organoid derived monolayers (inflamed and non-inflamed) of UC patients and non-IBD controls, stimulated with microbiota of patients or a healthy donor

Project description:Dysbiosis is linked to the pathogenesis of inflammatory bowel disease. Although there is a lot of interest in restoring the balance, we do not understand the effects of dysbiosis, especially on epithelial cells. In addition, we know that epithelial cells from IBD patients maintain intrinsic defects. For that reason, we aimed to unravel if epithelial cells of UC patients are more sensitive towards microbiota stimulation, compared to non-IBD controls. In addition, we analyzed the effect of UC microbiota or microbiota of healthy donors towards epithelial cells. Confluent organoid derived monolayers of 8 UC patients and 8 non-IBD controls were co-cultured for 6 hours with microbiota (3.10^8 cells) , derived of a healthy donor (HD) or UC patients. If applicable, epithelial cells were first cultured for 24 hours with an inflammatory mix (100 ng/mL TNFα, 20 ng/mL IL1β, 1 µg/mL Flagellin). The inflammatory stimulation was continued in the 6 hours co-culture.Transcriptomic expression of epithelial cells was evaluated after 6 hours co-culture by Truseq for Illumina.

2022-07-31 | E-MTAB-10832 | biostudies-arrayexpress

IBD Siblings Study

Project description:Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.

| PRJEB76677 | ENA

IBD

Project description:WTCCC1 project Inflammatory Bowel Disease (IBD) samples

| EGAD00000000005 | EGA

Label free-DDA nano-LC/MS/MS analysis of Human Mesenteric lymph collected from Inflammatory Bowel Disease (IBD) subjects.

Project description:Compromise of the intestinal barrier have been associated with a series of inflammatory conditions where the routine controls nutrient absorption and pathogens exclusion is lost to different degrees. The intestinal epithelial cells form a barrier of selective permeability which protects from invasion by the normal bacteria present in the gut. When the barrier is compromised, bacteria and their products can attack the cells and cause inflammation, which can (in severe cases) cause sepsis. Mesenteric lymph nodes play a crucial role in the immune response and are of particular importance in the study of Inflammatory Bowel Disease (IBD) patients due to their involvement in the disease process. To assess the efficiency of gut immune barrier, we collected the pre-nodal lymph from Inflammatory Bowel Disease (IBD) subjects and performed a comprehensive proteomic analysis. The current study is complementary extension of the proteomics signature found in DSS-induced colitis mouse model, providing an insight in the lymph composition, and associated biochemical changes, in the set of samples (n=6) recruited from the Inflammatory Bowel Disease (IBD), subjects undergoing intestinal resection. Following bottom-up analysis, the enrichment analysis – GO and Ingenuity pathway analysis (IPA) analysis identified several pathways pointing towards a damaging phenotype.

2024-08-09 | PXD044801 | Pride

Whole exome sequencing of inflammatory bowel disease cases

Project description:Whole exome sequencing of around 700 inflammatory bowel disease cases.

| EGAS00001000530 | EGA

IBD-T2DM

Project description:Gut Microbiota Analyses of Inflammatory Bowel Diseases from a representative Saudi Population

| PRJEB57347 | ENA

Predicting response to vedolizumab therapy using mucosal transcriptomics in IBD patients

Project description:In this study we wanted to identify baseline predictors of successful vedolizumab therapy in patients with inflammatory bowel disease.

2019-08-23 | E-MTAB-7845 | biostudies-arrayexpress

PICU cases

Project description:PICU cases

| PRJEB73551 | ENA